Hikma Pharmaceuticals has agreed to pay $50 million to settle a class action accusing the drugmaker of scheming to delay a ...

Hikma Pharmaceuticals said on Thursday that it has entered into a preliminary $50m class settlement agreement that resolves ...

Hikma Pharmaceuticals Plc reached a $50 million deal to settle claims it colluded with other drugmakers to delay the generic version of brand-name narcolepsy drug Xyrem.